Novartis AG is 62.2x more valuable than AMICUS THERAPEUTICS, INC. by market capitalization ($283.13 B vs $4.55 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | FOLD | NVS |
|---|---|---|
| Market cap | $4.55 B | $283.13 B |
| US-listed rank | #1468 | #47 |
| Revenue (latest FY) | $634.21M | - |
| Net income (latest FY) | -$27.11M | - |
| Net margin | -4.3% | - |
| SEC filings | 2,171 | 947 |
Novartis AG is 62.2x more valuable than AMICUS THERAPEUTICS, INC. by market capitalization ($283.13 B vs $4.55 B).
Full pages: AMICUS THERAPEUTICS, INC. and Novartis AG, or browse the full rankings.